A highly sensitive and rapid method for the determination of substance P (SP) and streptolysin O (SLO) in human serum is described. The assay is based on enriching the analyte by agglutination/precipitation of immuno-liposomes and enhancing the fluorescence intensity by gramicidin A channels. A mixture of the immuno-liposomes encapsulating a pH-sensitive fluorescence dye BCECF, gramicidin A and a given concentration of SP (or SLO) is preincubated in a solution and captured on anti-SP (or anti-SLO)-modified cover slips, followed by measuring fluorescence images after removing excess liposomes. The method allowed quantifying SP and SLO in the range from sub-pg mL -1 to pg mL -1 , with detection limits of 0.32 pg mL -1 and 8 fg mL -1 , respectively. The present method could determine SP and SLO in 50 -125 times diluted human serum without any extraction steps. The assay can be completed within 60 min.
Introduction
The undecapeptide substance P (SP), which is a member of the tachykinin family of neuropeptides, is widely distributed in the central, peripheral, and enteric nervous systems of many species. 1 SP has been implicated in pain transmission, respiration, cardiovascular control, 2 and numerous disease states, such as inflammatory disease, inflammatory arthritis, 3, 4 infectious disease, 5 Alzheimer's, 6 Parkinson's, 7 and Huntington's disease. 8 Therefore, accurate measurements of SP levels in biological fluids are important for the monitoring of various characteristics of health or disease and infection. SP levels in human serum are typically in the range from 10 to 220 pg mL -1 . 9-12 A variety of methods have been exploited for the quantification of SP in biological fluids, including HPLC, 13, 14 capillary electrophoresis, 15, 16 electrochemical methods, 17 ,18 radioimmunoassay (RIA) [19] [20] [21] [22] and competitive enzyme immunoassay (EIA). [23] [24] [25] The extraction of SP from biological fluids has frequently been used for enrichment of a smallmolecule weight peptide, i.e., SP, and the exclusion of largemolecular weight plasma or serum proteins. 14 However, endogenous SP in human plasma and serum is present in free and bound states; SP (MW 1347.6) reversibly and nonspecifically binds to proteins with high-molecular (> 400000 Da) and intermediate-molecular (58000 Da) mass. [26] [27] [28] Hence, the extraction procedure is likely to eliminate SP bound to proteins, leading to the underestimates of the total SP amount in the biological fluids. This may be the reason for a considerable variation in the reported levels of SP with or without extraction steps. 26, 27 In addition, not only SP, 9 but also total amount of serum and plasma proteins, vary under physiological and pathological conditions. 29, 30 RIA and EIA are highly sensitive methods that provide the possibility of measuring SP levels without any extraction steps. The dilution of serum or plasma samples increases the ratio of the probe antibody to serum or plasma proteins, allowing effective dissociation of nonspecifically bound SP from proteins. 26 However, RIA and EIA necessitate time-consuming procedures. Furthermore, the assay has to be highly sensitivity, because the SP levels are lowered by dilution.
We reported on a fluorometric method for SP 31 and hormones 32 by using a immuno-liposome array and a pore-forming peptide, i.e., gramicidin, which enhances fluorescence from pH-sensitive dye-encapsulating liposomes. However, the sensitivity of the gramicidin-aided method with a detection limit of sub-pg mL -1 was not sufficient for the assay of SP in diluted serum samples. In the present study, we combined the gramicidin-aided immunoassay with immune-precipitation techniques in order to improve the sensitivity and detection limit of our previous method (Fig. 1) . The improved method was applied to measurements of SP in diluted human serum without extraction steps. Also, the quantification of a potent exotoxin streptolysin O (SLO) in diluted human serum was investigated in order to demonstrate the potential of the present approach for detecting a variety of antigens at an early stage of infections. The present assay can quantify SP and SLO in human serum within 60 min.
Experimental

Materials
L-α-Phosphatidylcholine (PC, purity > 99%, 50 mg mL -1 chloroform solution), L-α-phosphatidylethanolamine (PE, 10 mg mL -1 chloroform solution) and 2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N- [4-(maleimidophenyl) butyrate] (N-MPB-PE, 10 mg mL -1 chloroform solution) were purchased from Avanti Polar Lipids (Alabaster, AL). Anti-substance P antibody (polyclonal, rabbit) (anti-SP), anti-SLO antibody (monoclonal, mouse) (anti-SLO) and SP were obtained from Funakoshi (Tokyo, Japan). Cholesterol (Chol) was obtained from Wako Pure Chemicals (Osaka, Japan), and recrystallized three times from methanol. 3-Mercaptopropyltrimethoxysilane (MTS, >99.9%) was obtained from Shin-Etsu Chemical (Tokyo, Japan). N-Succinimidyl 3-(2-pyridyldithio)-propionate (SPDP) was obtained from Thermo Scientific (Rockford, IL). Gramicidin A and SLO were purchased from Sigma Chemical (St. Louis, MO). 2′,7′-Bis(carboxyethyl)-4 or 5-carboxyfluorescein (BCECF) were obtained from Dojindo Laboratories (Kumamoto, Japan). Cysteamine and dimethyl sulfoxide (DMSO, dehydrated) was purchased from Wako Pure Chemicals. Calcein was obtained from Dojindo Laboratories. Substance P EIA kit was obtained from Cayman Chemical Co. (USA). All other chemicals used were of analytical reagent grade. Milli-Q water (Millipore reagent water system, Bedford, MA) was used throughout the experiments. Glass cover slips of 24 × 24 mm (0.17 -0.25 mm in thickness) were obtained from Matsunami Glass Industries (Tokyo, Japan).
A 30 μg mL -1 gramicidin A solution (abbreviated as a gramicidin solution) was prepared by diluting 3 mg mL -1 gramicidin A in methanol with a 0.10 M NaCl solution containing 10 mM NaH2PO4/NaOH (pH 7.8) (a PB solution). SP and SLO solutions were prepared by dissolving SP and SLO in a PB solution, respectively. These solutions were prepared immediately before their uses, and diluted further with a PB solution if necessary.
Apparatus
All fluorometric images of liposomes on cover slips were obtained with a FluorImager 595 (Molecular Dynamics, Sunnyvale, CA).
A Shimadzu (Kyoto, Japan) F-5300C spectrofluorophotometer was used for the determination of trapped volumes. Absorptiometric measurements were carried out with a Shimadzu spectrometer UV-2500. A Denki Kagaku Keiki (Tokyo, Japan) glass electrode pH meter (Model IOL30) was used for pH measurements.
Preparation of Fab'-fragments
Fab' fragments of anti-SP antibody (anti-SP) and anti-SLO antibody (anti-SLO) were prepared with a F(ab')2 preparation kit (Thermo Scientific), and used for coupling to liposomes. Briefly, a 3.5-mL portion of a F(ab')2-fragment solution was prepared. Then, the F(ab')2 fragment (3.5 mL) was reduced with a 175-μL portion of a cysteamine solution containing 0.15 M NaCl and 0.10 M sodium phosphate (pH 7.2). The Fab' fragment was purified with a desalting column (Thermo Scientific), and its concentration was determined by absorbance (A280) measurements. The purified Fab' fragment was washed three times with a gel filtration column (Amicon ultra-0.5, Millipore, Bedford, MA) using a PB solution, and stored in the presence of 0.010 M EDTA at 4 C under a nitrogen atmosphere. w/w) was dried to a lipid film, and subjected to a high vacuum. The lipid film was hydrated in a 1.0-mL portion of a 0.10 M NaCl solution (pH 4.8) containing 10 mM NaH2PO4/NaOH and 0.80 mM BCECF (abbreviated as an inner solution) by vortex mixing for 10 min, followed by bath sonication for 15 min. The mixture was centrifuged at 12000g at 4 C for 5 min to remove any excess BCECF from the outer solution. The precipitates were washed 3 -5 times with a 0.10 M NaCl solution containing 10 mM NaH2PO4/NaOH (pH 5.5). The BCECF-encapsulating liposomes were collected by centrifugation (12000g), and finally suspended with 1.0 mL of a PB solution, giving a 27 mg mL -1 suspension. The trapped volume was 3.3 ± 1.2% (n = 3) for the liposomes, as determined according to the literature. 33 The fluorescence intensity of the thus-prepared liposomes was (7.63 ± 1.0)× 10 4 (6 preparations), showing the reproducibility of the dye entrapment.
Preparation of BCECF-encapsulating liposomes and immunoliposomes
Liposome precipitates obtained from 0.1 mL of its suspension by centrifugation were incubated overnight at 4 C with a 0.4-mL portion of a Fab' fragment in a PB solution (130 μg mL -1 anti-SP or anti-SLO). An excess Fab' fragment was removed by washing the suspension three times with a PB solution using centrifugation (13000g) at 20 C, followed by treatment with 0.40 mL of 0.04 M cysteamine in a PB solution. The precipitates obtained by centrifugation were finally dispersed in a 0.10-mL portion of a PB solution (an outer solution), and stored under nitrogen at 4 C until use. A pH gradient established between the inner solution (initial pH 4.8) and the outer solution (pH 7.8) was maintained even after 24 h ( 
Preparation of antibody slips
Cover slips were modified with anti-SP antibody as follows. Cover slips (24 × 24 mm) were cleaned in 1 M NaOH overnight and washed thoroughly with Milli-Q water. The one-side surface of a cover slip was treated with 0.25 mL of 50% (v/v) MTS in toluene for 60 min at room temperature. The MTS-modified cover slip was washed with toluene and dried at room temperature. On the other hand, a 40-μL portion of an anti-SP antibody (not fragmented) solution was diluted with 160 μL of a PB solution to give a 1 mg mL -1 solution, followed by mixing with 2.5 μL of 20 mM SPDP in dimethyl sulfoxide (DMSO, anhydrous). Since an anti-SP antibody (not fragmented) was used, the interaction of SPDP with the sulfhydryl moiety, if present, of the antibody was avoided. Then, the mixture was incubated for 1 h at room temperature. Unreacted SPDP was removed and replaced by a PB solution using a dye removal column (Thermo Scientific, Rockford, IL). Then, a 20-μL portion of the activated anti-SP (0.1 mg mL -1 ) was placed on a MTS-modified cover slip and incubated for 60 min at 4 C. The cover slip was washed with Milli-Q water and stored in a PB solution. The anti-SP-cover slip is hereafter abbreviated as an anti-SP slip. Anti-SLO antibody-modified slips were also prepared in the same manner as that for anti-SP slips. Both slips were used for successive experiments without storage.
It is noted that anti-SP antibody may contain a number of amino sites in its molecule, and hence amine sites are multiply activated by SPDP. The SPDP-activated anti-SP can react with the sulfhydryl groups on the glass slip. Hence, excess SPDP sites of the antibody may remain free. However, SP molecules do not contain cysteine, and further unreacted maleimido sites of the Fab'-modified liposomes were blocked by cysteamine (vide supra). Consequently, free SPDP sites did not affect the quantification of the assay.
Assay of SP and SLO in human serum
Human serum (type AB, male, H4522-20ML, Sigma) was diluted 125 times with a PB solution; 10 μL of serum was mixed with 1.24 mL of a PB solution. For the case of SLO quantification, a known amount of SLO in a PB solution was spiked into the diluted serum. A 5-μL portion of the diluted serum sample was taken and mixed with 5.0 μL of 30 μg mL 
The determination of SP and SLO amounts in serum were based on calibration curves prepared using a known concentration of each compound in a PB solution (vide infra).
Quantification of SP levels using competitive enzyme immunoassay
To demonstrate the accuracy of the present method, the quantification of SP in human serum was performed using a commercial EIA kit (Cayman Chemical Co., USA). Before SP measurements, human serum was diluted 15 or 20-times with an EIA buffer solution, supplied as the assay kit. Absorbance measurements at 405 nm were performed with a Sunrise absorbance reader (TECAN Group Ltd., Switzerland).
Results and Discussion
Selective capture of Fab'(anti-SP)-liposome on an anti-SP slip
The effect of nonspecific adsorption of Fab'(anti-SP)-liposome and/or agglutination between SP (100 pg mL -1 ) and Fab'(anti-SP)-liposome (2.7 mg mL -1 ) on the quantification of SP with an anti-SP slip was investigated (Fig. 2a) . In the absence of SP, a weak fluorescence intensity was observed, which indicates nonspecific adsorption of the Fab'(anti-SP)-liposome (column 2). However, the intensity in the presence of SP (column 1) was significantly larger than that in its absence. In addition, when an anti-BSA antibody-modified slip was used in place of an anti-SP slip, the fluorescence intensity (column 3) was almost the same level as that observed with an anti-SP slip in the absence of SP. Combining these results, we conclude that the selective capture of Fab'(anti-SP)-liposome on the anti-SP slip necessitates the presence of SP.
Evidence for the agglutination of Fab'(anti-SP)-liposome in the presence of SP is shown in Fig. 2b . When Fab'(anti-SP)-liposome in the presence of SP and gramicidin was preincubated in a PB solution, and its mixture was captured on an anti-SP slip, the observed fluorescence intensity was significantly larger than that obtained by simply capturing Fab'(anti-SP)-liposome on a SP-bound anti-SP slip (t-test, P = 0.05, n = 4 -8). This suggests that some fractions of Fab'(anti-SP)-liposome in the presence of SP are agglutinated in a PB solution. The fluorescence intensity of the captured liposome in the presence of SP increased with an increase in the liposome concentration, ranging from 2.7 × 10 -2 mg mL -1 to 2.7 mg mL -1 (curve 1 in Fig. 2c ), while that of the captured liposome in the absence of SP was saturated (curve 2 in Fig. 2c ). This shows that the agglutination proceeds more with an increase in the liposome concentration.
The preincubation of 15 min in a PB solution was sufficient for the agglutination between Fab'(anti-SP)-liposome and SP (1.0 × 10 -10 g mL -1 ), and the spontaneous incorporation of gramicidin A into lipid bilayers (curve 1 in Fig. S2 , Supporting Information).
The time-dependent fluorescence intensity observed in the absence of gramicidin (curve 2 in Fig. S2) shows that the agglutination of Fab'(anti-SP)-liposome with SP proceeds gradually. It is noted that the time needed for scanning the cover slip was 3 min, and hence the fluorescence intensity was monitored at a given time interval until 30 min in order to avoid any photo bleaching effect of the dye. On the other hand, capturing the SP-bound Fab' (anti-SP)-liposome onto an anti-SP slip was achieved by incubation for 15 min (Fig. S3, Supporting  Information) . Figure 3a shows the effect of the outer solution pH on the gramicidin-aided fluorescence enhancement of Fab'(anti-SP)-liposome having an inner solution of pH 4.8. The fluorescence intensity in the presence of 1.0 × 10 -10 g mL -1 SP increased with an increase in the outer solution pH up to 7.8. Considering that the fluorescence of Fab'(anti-SP)-liposome in the absence of gramicidin remains unchanged even after 24 h (Fig. S1 ), the results show that H + ions in the inner solution were released through gramicidin channels following the pH gradient. The pH rise of the inner solution leads to a shift in the acid dissociation equilibrium of BCECF toward the dissociated form, resulting in a larger fluorescence intensity. When an outer solution of pH 7.8 was used, the fluorescence intensity of Fab'(anti-SP)-liposome in the presence of SP and gramicidin A was about 2.2-times larger than that without gramicidin (Fig. 3b) . This shows that the addition of gramicidin is effective for enhancing the fluorescence from BCECF encapsulated in Fab'(anti-SP)-liposome.
Effect of pH gradients on the fluorescence intensity
Concentration dependence
The concentration dependence for SP in a PB solution with the present method is shown in Fig. 4 , where the fluorescence intensity is plotted against the SP concentration in the range from 1.0 × 10 -13 to 1.0 × 10 -12 g mL -1 on a linear scale (Fig. 4a ) and a logarithmic scale (Fig. 4b) . The fluorescence intensity increased steeply with the SP concentration up to 1.0 × 10 -12 g mL -1 . On the other hand, on a logarithmic scale, the fluorescence intensity was linearly related to an increase in the SP concentration. The lower detection limit for SP was 0.32 pg mL -1 , as calculated from the fluorescence intensity at three-times the standard deviation of the fluorescence intensity in the absence of SP. The lower detection limit was comparable to that (0.25 pg mL -1 ) of the competitive fluorometric immunoassay, 34 but it was much superior to those of the liposome array method (sub-pg mL -1 ), 31 as well as the radioimmunoassay (10 -20 pg mL -1 ), 35, 36 the solid-phase immobilized epitope immunoassay (6 pg mL -1 ) 37 and the amperometric micro-immunosensor (10 pg mL -1 ). 18 
Effect of human serum albumin (HSA) and serum dilution
The effect of human serum albumin (HSA) and γ-globulin on the assay of SP was investigated by quantifying SP (1.0 pg mL -1 ) in the presence of HSA, ranging from 0 to 10 mg mL -1 , and γ-globulin (0.5 mg mL -1 ). As shown in Fig. 5 , the fluorescence intensity remained almost constant even in the presence of HSA up to 10 mg mL -1 , indicating that the presence of HSA did not affect the quantification of SP. Similarly, γ-globulin (0.5 mg mL -1 ) did not affect the assay of SP. The effect of the dilution of human serum with a PB solution on the determination of SP levels is shown in Fig. 6 . The SP level in 100% human serum decreased with the dilution rate, and became constant beyond 50-times dilution. With 125-times dilution, the SP amount in 100% human serum was obtained as (2.2 ± 0.6)× 10 2 pg mL -1 (Table 1 ). This concentration was in the range of the reported SP levels in human serum. [10] [11] [12] The SP level was the same as that obtained at 50-times dilution. This shows that SP bound to serum proteins was almost fully dissociated. The SP level in human serum was compared with that obtained with a competitive EIA kit (Cayman EIA kit) (Fig. S4, Supporting Information) . For the assay using the kit, human serum was diluted 15 or 20 times with an EIA buffer ( Table 1 ). The EIA showed that the amount of SP in 100% human serum is (1.7 ± 0.2)× 10 2 pg mL -1 . No static difference was found between the results obtained with the preset assay and the EIA method (t-test, P = 0.05).
When the dilution rate of human serum was low, i.e., below 25 times, the observed SP level in 100% human serum was larger than those obtained from other dilution rates. Our speculation for this phenomenon is that the extent of agglutination of Fab' (anti-SP)-liposome was modified by the presence of Ca 2+ and Mg 2+ in serum and/or the adsorption of endogenous proteins on the liposome. Consequently, the present method allows for the quantification of SP in highly diluted serum.
Detection of SLO in human serum
Taking advantage of the sensitive and rapid assay, we investigated the quantification of SLO in diluted human serum. SLO is a 63 kDa exotoxin that damages cholesterol-containing membranes, resulting in disruption and lysis of the target cell. 38, 39 SLO elicits an antibody response in the host during beta-hemolytic streptcoccal (GABHS) infections. Measurements of elevated levels of anti-streptolysin O antibody (ASO) in serum are used for diagnosing streptococcal infections, such as rheumatic fever and glomerulonephritis. [40] [41] [42] [43] [44] [45] Quantifying SLO rather than ASO may help us to know an earlier stage of the exotoxin infections, where the production of ASO is not yet sufficient for detection with ELISA methods.
The obtained results are given in Table 2 . The recovery of the spiked SLO was calculated from a calibration curve in a PB solution (Fig. S5, Supporting Information) . The recovery was slightly lower than 100%. This is probably because of the binding of components, like peptides with small-molecular weight to protein SLO and/or the interaction of SLO with the lipid bilayer of the immuno-liposome, which does not contribute to an enhancement of the fluorescence signal.
The calibration of the fluorescence response with SLO in a PB solution gave a detection limit of 8 fg mL -1 , which is superior to that for SP (vide supra). This superior detection limit is ascribable to the large-molecular weight of SLO, which may lead to a larger modulation of gramicidin kinetics. The determination of SLO has been reported based on using a surface-bound lipid vesicle on a gold electrode, in which an electro-active marker is encapsulated. 46 As compared with the dynamic range (5 -45 HU) of the electrochemical method, the present method is very sensitive, though the dynamic range is comparable, i.e., 5.8 × 10 -7 -5.8 × 10 -6 U SLO.
Conclusions
The present paper described a sensitive and rapid assay of SP and SLO in highly diluted human serum samples. The combination of the gramicidin-aided fluorescence enhancement with the capture of Fab' fragment-modified liposome on an antibody slip enabled us to detect SP at sub-pg mL -1 to hundreds pg mL -1 level. By virtue of the high sensitivity, the measurements of SP and SLO in highly diluted human blood serum were achieved without any extraction steps. If Fab' fragments of other antibodies are linked to liposomes, this method can be applied to the detection of various biomolecules, which exist in very low levels at early stages of the disease, and at normal conditions. Table 1 Comparison of the proposed method and a competitive EIA method for the determination of SP levels in human serum Relationship between the SP levels and the dilution rates of human serum. Human serum was diluted with a PB solution and subjected to a fluorometric assay. The error bars indicate the mean ± standard deviation. Ex. 488 nm; Em. 530 nm
